Home/Filings/3/0000899243-18-020088
3//SEC Filing

Mountain Berg Ltd 3

Accession 0000899243-18-020088

CIK 0001434418other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 5:29 PM ET

Size

7.2 KB

Accession

0000899243-18-020088

Insider Transaction Report

Form 3
Period: 2018-07-18
Holdings
  • Series E Preferred Stock

    Common Stock (51,905 underlying)
  • Series E-1 Preferred Stock

    Common Stock (54,894 underlying)
  • Series F Preferred Stock

    Common Stock (68,127 underlying)
Footnotes (3)
  • [F1]The Series E Preferred Stock is convertible into Common Stock on a 8.56256-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
  • [F2]The Series E-1 Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
  • [F3]The Series F Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.

Issuer

CONSTELLATION PHARMACEUTICALS INC

CIK 0001434418

Entity typeother
IncorporatedUnited Kingdom

Related Parties

1
  • filerCIK 0001746350

Filing Metadata

Form type
3
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:29 PM ET
Size
7.2 KB